AC
BIVIW

Armistice Capital’s BioVie Inc Warrant BIVIW Stock Holding History

Armistice Capital’s Portfolio BIVIW Stock Details BIVIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$155K Hold
500,000
– – ﹤0.01% 235
2025
Q4 		$129K Buy
+500,000
New +$164K ﹤0.01% 352

Other funds holding BIVIW

DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.64B AUM 19.37% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Armistice Capital's BIVIW Position: Q1 2026 in Review

Armistice Capital held its BioVie Inc Warrant (BIVIW) position steady in Q1 2026 at 500,000 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #235.

Armistice Capital first reported a position in BIVIW in Q4 2025 and has held it in 2 quarters since. 8 funds tracked by Wall St. Rank hold BIVIW as of Q1 2026.

  • Armistice Capital held 500,000 shares of BioVie Inc Warrant worth $155K as of Q1 2026.
  • Armistice Capital left its BioVie Inc Warrant share count unchanged in Q1 2026.
  • BioVie Inc Warrant made up ﹤0.01% of Armistice Capital's portfolio in Q1 2026, its #235 holding.
  • Armistice Capital first reported a position in BioVie Inc Warrant in Q4 2025 and has held it in 2 quarters since.
  • 8 funds tracked by Wall St. Rank held BioVie Inc Warrant as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.